Oncology Nurse Interview Questions
& Model Answers, 2026

An independent double-check by two chemotherapy-competent nurses against the original order and the regimen: patient identity, drug, dose against body surface area or weight and any dose modification, route, rate, sequence, cumulative lifetime dose where relevant, laboratory parameters and organ function, consent, and blood counts. Verify blood return and line patency before a vesicant. The word interviewers listen for is independent.

Stop the infusion immediately without removing the cannula, disconnect and attempt to aspirate residual drug through it, notify the provider, follow the drug-specific management including any antidote and whether warm or cold compresses are indicated, mark and photograph the area, elevate, and document exactly. Then follow up, because tissue damage can evolve over days. Continuing the infusion to see if it settles is the error this question exists to catch.

Treat it as an emergency: cultures then broad-spectrum antibiotics within the target window — commonly one hour — because delay increases mortality, alongside full assessment for a source, vital signs and perfusion, and escalation for signs of sepsis. Do not wait for the counts to confirm what you already suspect. Say that neutropenic patients often lack the usual signs of infection.

Double chemotherapy-tested gloves, a coated gown, eye and respiratory protection where splashing or aerosol is possible, closed-system transfer devices, no priming with the drug at the bedside, dedicated hazardous waste and linen streams, and a spill kit with a team who knows where it is. Body fluids remain hazardous for a period after administration, which is the part most often forgotten.

Febrile neutropenia, tumour lysis syndrome, superior vena cava obstruction, malignant spinal cord compression, hypercalcaemia of malignancy, and severe infusion or cytokine release reactions. Give the presenting sign for each — new back pain with neurological change, facial swelling and distended neck veins, confusion with dehydration — because recognising them early is the skill being tested.

Stop the infusion, maintain the line with fluid, assess airway, breathing and circulation, call for help, give the ordered agents per grade of reaction, and monitor closely. Restart only per protocol at a reduced rate if the reaction was mild and it is ordered. Document the grade and the timing precisely, because it determines whether they can receive the drug again.

Prevent rather than rescue: give the antiemetic regimen matched to the emetogenic potential before treatment, continue through the delayed phase, and educate the patient on what to take at home and when to call. Then manage mucositis, neuropathy, fatigue and diarrhoea with grading, so escalation is objective. Patients who suffer nausea from cycle one are harder to control for every cycle after.

Describe following the physician's disclosure with the nursing work: checking what they understood, answering honestly, sitting with the silence, and helping them get to the questions they actually wanted to ask. Then supporting the goals-of-care and palliative referral conversation. Interviewers want evidence you stay in the room rather than becoming busy elsewhere.

Give the specific catch — a dose not adjusted for a changed weight or renal function, a wrong sequence, an out-of-date order, a laboratory value that should have held treatment — and that you stopped, escalated and reported it. Oncology depends on the second nurse actually checking rather than co-signing, and this is where you demonstrate that you do.

Oncology relationships are long, and the honest answer includes the difficulty of that: what you learned about them, how you kept professional boundaries while genuinely caring, and how you handled it when they deteriorated or died. Managers know that the depth of these relationships is both the reward and the burnout risk.

Specific, non-performative answers: debriefs, memorial or reflection practices the unit holds, peer support, supervision, boundaries and time off, and knowing your own warning signs. Oncology turnover is driven by cumulative grief, so a candidate who has thought about it concretely is a lower risk than one who says they are used to it.

Anchor on the published series and note its breadth: registered nurses have a BLS OEWS May 2025 median of $97,550 a year ($46.90/hr) with the top 10% above $137,470 across all specialties. Oncology with OCN certification and chemotherapy competency negotiates in the upper half; quote a range and cite your certification, regimens and setting.

Outpatient infusion typically offers predictable daytime hours without nights, weekends or call, which many nurses trade some differential income for; inpatient carries differentials and higher acuity. Say which you are targeting and why, and evaluate the total package — schedule, differentials, patient volume per nurse — rather than the base alone.

Ladder placement, OCN certification and the chemotherapy provider course paid with a differential, orientation length with a chemotherapy-competent preceptor, a defined patient-to-nurse ratio in the infusion suite, and access to clinical trial training. Trial-capable nurses are in demand, and that training is a durable career asset.